Test Directory
| Test Code | ||||
| HCGT | ||||
| Test Name | ||||
| Beta-hCG, Quantitative (Tumor Marker), CSF | ||||
| CPT Codes | ||||
| 84702 | ||||
| Expected Turnaround Time | ||||
| 1 day | ||||
| Clinical Utility | ||||
|
Human chorionic gonadotropin (hCG) is a valuable aid in the management of patients with trophoblastic tumors, nonseminomatous testicular tumors, and seminomas when used in conjunction with information available from the clinical evaluation and other diagnostic procedures. Increased hCG concentrations have also been observed in melanoma, carcinomas of the breast, gastrointestinal tract, lung, and ovaries, and in benign conditions including cirrhosis, duodenal ulcer, and inflammatory bowel disease. |
||||
| Specimen and Container Info | ||||
|
Specimen Type: Cerebrospinal Fluid
Collection Container: Sterile, Non-Additive Container (CSF) Alternate Collection Container: Red Top, Plain Desired Specimen Volume: 0.5 mL |
||||
| Collection Instructions | ||||
|
||||
| Processing and Submission Instructions | ||||
|
||||
| Transport Instructions | ||||
|
Transport to the laboratory refrigerated. |
||||
| Stability Requirements | ||||
|
||||
| Methodology | ||||
| Quantitative Electrochemilluminescent Immunoassay | ||||
| Reference Intervals | ||||
|
See patient report. |
||||
| Limitations | ||||
|
The result cannot be interpreted as absolute evidence of the presence or absence of malignant disease. The result is not interpretable as a tumor marker in pregnant females. |
||||
| Alternate Names | ||||
|
||||
| Reference Lab | ||||
| ARUP Laboratories | ||||
| Testing Schedule | ||||
| Routine, daily | ||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.